KEGG   DRUG: Darvadstrocel
Entry
D11397                      Drug                                   

Name
Darvadstrocel (INN);
Alofisel (TN)
Remark
ATC code: L04AX08
Efficacy
Anti-inflammatory
Comment
Cellular therapy product
Treatment of complex perianal fistulas in adult patients with Crohn's disease (a disease causing inflammation of the gut)
Target
IFNG [HSA:3458] [KO:K04687]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04350  TGF-beta signaling pathway
hsa05321  Inflammatory bowel disease
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L04 IMMUNOSUPPRESSANTS
   L04A IMMUNOSUPPRESSANTS
    L04AX Other immunosuppressants
     L04AX08 Darvadstrocel
      D11397  Darvadstrocel (INN)
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokines
   Interferons
    IFNG
     D11397  Darvadstrocel (INN)
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11397
 Cellular and gene therapy products
  D11397
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11397
Other DBs
PubChem: 384585375
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system